AVROBIO, Inc. (AVRO) has an overall financial health rating of B+ with a composite score of 0 out of 5.
This suggests the company faces some financial challenges worth monitoring. Rating as of 2024-06-20.
| Date | Rating | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2024-06-20 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-06-18 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-06-17 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-06-14 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-06-13 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-06-12 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-06-11 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-06-10 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-06-07 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-06-05 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-06-04 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-06-03 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 |
